Comprehensive Assessment of Head and Neck Cancer Survivors
CAHNCA
A Comprehensive Assessment of Adult Head and Neck Cancer Survivors (A Pilot Study)
1 other identifier
observational
15
1 country
2
Brief Summary
Cancer survivorship has dramatically improved within the last four decades and a greater number of Americans are living after cancer diagnosis. An increase in the number of survivors has highlighted the need to investigate the quality of life experienced by these survivors. While Survivorship research has improved our understanding of the challenges faced by some cancer survivors, there is a paucity of research on the functional and cognitive health status of head and neck cancer survivors. The purpose of this study is to evaluate the functional and cognitive changes that occur in head and neck cancer patients as a result of cancer treatment, in an attempt to increase our understanding of the complex interactions between cancer treatment, comorbid health ailments and quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jul 2009
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2009
CompletedFirst Submitted
Initial submission to the registry
October 15, 2010
CompletedFirst Posted
Study publicly available on registry
October 18, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2012
CompletedMarch 2, 2012
February 1, 2012
2.6 years
October 15, 2010
February 29, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Functional and Cognitive health status
At the time of cancer diagnosis and Within 1 month of cancer therapy
Secondary Outcomes (1)
Assess the effectiveness of novel performance-based tests in detecting subtle functional and cognitive health status changes
At the time of cancer diagnosis and Within 1 month of cancer therapy
Study Arms (1)
Newly-diagnosed Head and Neck Cancer
Eligibility Criteria
Participants will be recruited from the Washington University Physicians Faculty Practice clinics of Adult Otolaryngology, Medical Oncology and Radiation Oncology
You may qualify if:
- Subjects must be 40 years of age or older.
- Subjects must be able to read, write and speak English fluently.
- Subjects must be newly diagnosed with head and neck squamous cell cancer.
- Subjects must not have already had treatment for this cancer diagnosis.
- Subjects must be anticipated to receive at least one of the following types of therapy: surgery, chemotherapy or radiation.
You may not qualify if:
- Subjects with prior cancer diagnoses who have evidence of active disease.
- Subjects who have received cancer treatment within the past year.
- Subjects who have received chemotherapy or radiation treatment within the past year (for any disease state).
- Life expectancy of less than 3 months.
- Subjects with melanoma or other non-squamous cell cancer.
- Subjects who score \>9 on Short Blessed Test (SBT) at baseline.
- Subjects who are unable to complete all of the required forms and tasks at baseline, either because of cognitive deficits or physical limitations.
- Any medical condition the PI determines to affect safe study participation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jay F. Piccirillo, MDlead
- University of Alabama at Birminghamcollaborator
Study Sites (2)
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
Washington University School of Medicine
St Louis, Missouri, 63110, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Oluwafunmilola T Okuyemi, MD
Washington University School of Medicine
- STUDY DIRECTOR
Jay F Piccirillo, MD, FACS
Washington University School of Medicine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor, Washington University School of Medicine
Study Record Dates
First Submitted
October 15, 2010
First Posted
October 18, 2010
Study Start
July 1, 2009
Primary Completion
February 1, 2012
Study Completion
February 1, 2012
Last Updated
March 2, 2012
Record last verified: 2012-02